Now accepting Telehealth appointments. Schedule a virtual visit.

New Stanford Medicine Study Finds a 90% Success Rate for Depression

To find the full study, click here.

A sample of 21 participants experiencing severe depression and was unresponsive to anti-depressant medications, talk therapy, or other forms of electromagnetic stimulation such as ECT, was recruited in a small study designed by Stanford Professors. The researchers used a form of Transcranial Magnetic Stimulation, or TMS, called intermittent theta burst stimulation (iTBS) to treat the participants with depression. This stimulation mimics the brain's natural firing patterns during memory processing. TMS is an FDA approved, noninvasive, and safe therapy for treatment resistant depression. Upon completion of this study, they concluded that TMS rapidly relieved symptoms of severe depression in 90% of participants. This was quantified by a score of less than 11 on the Montgomery-Asberg Depression Rating Scale. The researchers are conducting a larger, double-blinded trial in hopes that the second trial will prove to be similarly effective. 

According to Nolan Williams, MD, assistant professor of psychiatry and behavioral sciences and senior author of this study, he mentioned that, "There has never been a therapy for treatment resistant depression that's broken 55% remission rates in open-label testing." He also added that electroconvulsive therapy (ECT) was thought to be the gold standard, but it only has an average of a 48% remission rate in treatment resistant depression. However, ECT has a list of side effects and is more invasive when compared to TMS. So a 90% remission rate for treatment resistant depression is huge in the field of psychiatry. One patient undergoing the study even quoted, "I used to cry over the slightest thing,” she said. “But when bad things happen now, I’m just resilient and stable. I’m in a much more peaceful state of mind, able to enjoy the positive things in life with the energy to get things done.” 

If you think you can benefit from the TMS treatment, give us a call at (714) 867-7037 for more information and to schedule an appointment. TMS is covered by most insurances and is FDA approved to treat depression for adults over the age of 18 years old. 


You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).